Influence of Weight and Body Size on the Pharmacokinetics of Heart Failure Pharmacotherapy: A Systematic Review.

Hindi, Jessica; Fréchette-Le Bel, Myriam; Rouleau, Jean Lucien; de Denus, Simon

Hindi, Jessica; Fréchette-Le Bel, Myriam; Rouleau, Jean Lucien; de Denus, Simon.

Affiliation

Hindi J; Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada.
Fréchette-Le Bel M; Montreal Heart Institute, Montreal, QC, Canada.
Rouleau JL; Beaulieu-Saucier Pharmacogenomics Center, Université de Montréal, Montreal, QC, Canada.
de Denus S; Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada.

Ann Pharmacother ; 58(3): 255-272, 2024 Mar.

Article in En | MEDLINE | ID: mdl-37338205

Subject(s)

Heart Failure; Humans; Heart Failure/drug therapy; Valsartan/therapeutic use; Metoprolol/therapeutic use; Carvedilol/therapeutic use; Body Size; Adrenergic beta-Antagonists/therapeutic use

Key words

ACE inhibitors; angiotensin receptor blockers; beta-blockers; body mass index; cardiac glycosides; heart failure; loop-diuretics; mineralocorticoid receptor antagonists; pharmacokinetics; weight

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Heart Failure Type of study: Systematic_reviews Limits: Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google